Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Huys, Isabelle" or (type any "bookEditor journalEditor issueEditor" and editor="Huys, Isa...

Add to list
- Journal Article
- A1
- open access
Off-patent biologicals and biosimilars tendering in Europe : a proposal towards more sustainable practices

Liese Barbier, Steven Simoens, Caroline Soontjens, Barbara Claus (UGent) , Arnold G. Vulto and Isabelle Huys

(2021) PHARMACEUTICALS. 14(6).
Add to list
- Book Chapter
- open access
An overview of Belgian legislation applicable to biobank research and its interplay with data protection rules

Teodora Lalova, Anastassia Negrouk, Laurent Dollé, Sofie Bekaert (UGent) , Annelies Debucquoy, Jean-Jacques Derèze, Peggy Valcke, Els J. Kindt and Isabelle Huys

(2021) GDPR and biobanking : individual rights, public interest and research regulation across Europe. In Law, Governance and Technology Series 43. p.187-213
Add to list
- Book Chapter
- open access
Biobanking across Europe post-GDPR : a deliberately fragmented landscape

Olga Tzortzatou, Santa Slokenberga, Jane Reichel, Andreia da Costa Andrade, Carla Barbosa, Sofie Bekaert (UGent) , Evert-Ben van Veen, Carlos M. Romeo-Casabona, Katharina Ó. Cathaoir, Gauthier Chassang, et al.

(2021) GDPR and biobanking : individual rights, public interest and research regulation across Europe. In Law, governance and technology series 43. p.397-419
Add to list
- Journal Article
- A2
- open access
Developing a methodology to balance benefit-sharing : application in the context of biodiversity beyond national jurisdiction

Jane Eva Collins, Aysegül Sirakaya (UGent) , Thomas Vanagt and Isabelle Huys

(2020) GENETIC RESOURCES. 1(1). p.24-39
Add to list
Public views on genetics and genetic testing : a survey of the general public in Belgium

Davit Chokoshvili, Carmen Belmans, Roxanne Poncelet, Sofie Sanders, Deborah Vaes, Danya Vears, Sandra Janssens (UGent) , Isabelle Huys and Pascal Borry

(2017) GENETIC TESTING AND MOLECULAR BIOMARKERS. 21(3). p.195-201
Add to list
- Journal Article
- A1
- open access
Policies for biosimilar uptake in Europe : an overview

Evelien Moorkens, Arnold G Vulto, Isabelle Huys, Pieter Dylst, Brian Godman, Simon Keuerleber, Barbara Claus (UGent) , Maria Dimitrova, Guenka Petrova, Ljiljana Sović-Brkičić, et al.

(2017) PLOS ONE. 12(12).
Add to list
Chemotherapy drug shortages in paediatric oncology : a 14-year single-centre experience in Belgium

Tieneke Bauters (UGent) , Barbara Claus (UGent) , Koen Norga, Isabelle Huys, Steven Simoens and Genevieve Laureys (UGent)

(2016) JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 22(6). p.766-770
Add to list
- Miscellaneous
A bacteriophage journey at the European Medicines Agency

Laurent Debarbieux, Jean-Paul Pirnay, Gilbert Verbeken, Daniel De Vos, Maia Merabishvili (UGent) , Isabelle Huys, Olivier Patey, Dirk Schoonjans, Mario Vaneechoutte (UGent) , Martin Zizi, et al.

(2016) FEMS MICROBIOLOGY LETTERS. 363(2).
Add to list
- Journal Article
- A1
- open access
Quality and safety requirements for sustainable phage therapy products

Jean-Paul Pirnay, Bob G. Blasdel, Laurent Bretaudeau, Angus Buckling, Nina Chanishvili, Jason R. Clark, Sofia Corte-Real, Laurent Debarbieux, Alain Dublanchet, Daniel De Vos, et al.

(2015) PHARMACEUTICAL RESEARCH. 32(7). p.2173-2179
Add to list
Key issues in phage therapy: a report of a dedicated workshop at the viruses of microbes II meeting

Isabelle Huys, Mario Vaneechoutte (UGent) , Gilbert Verbeken (UGent) and Laurent Debarbieux

(2013) RESEARCH IN MICROBIOLOGY. 164(7). p.806-810

Academic Bibliography

Off-patent biologicals and biosimilars tendering in Europe : a proposal towards more sustainable practices

An overview of Belgian legislation applicable to biobank research and its interplay with data protection rules

Biobanking across Europe post-GDPR : a deliberately fragmented landscape

Developing a methodology to balance benefit-sharing : application in the context of biodiversity beyond national jurisdiction

Public views on genetics and genetic testing : a survey of the general public in Belgium

Policies for biosimilar uptake in Europe : an overview

Chemotherapy drug shortages in paediatric oncology : a 14-year single-centre experience in Belgium

A bacteriophage journey at the European Medicines Agency

Quality and safety requirements for sustainable phage therapy products

Key issues in phage therapy: a report of a dedicated workshop at the viruses of microbes II meeting

Contents

Support

Contact